Paricalcitol manufacturers and suppliers

Paricalcitol suppliers

Properties

Boiling point:: 564.8±50.0 °C(Predicted)

Density: 1.121±0.06 g/cm3(Predicted)

Flash point:: 14℃

storage temp.: Store at -20°C,unstable in solution, ready to use.

solubility: DMSO : 100 mg/mL (240.02 mM; Need ultrasonic)Ethanol : 12.5 mg/mL (30.00 mM; Need ultrasonic)H2O : < 0.1 mg/mL (insoluble)

pka: 14.34±0.40(Predicted)

form: Solid

color: White to off-white

InChIKey: BPKAHTKRCLCHEA-UBFJEZKGSA-N

SMILES: C[C@]12CCC/C(=C\C=C3C[C@@H](O)C[C@H](O)C3)/[C@]1([H])CC[C@]2([H])[C@H](C)/C=C/[C@H](C)C(O)(C)C |&1:1,10,13,16,20,22,26,r|

CAS DataBase Reference: 131918-61-1(CAS DataBase Reference)

Safety Information

Symbol(GHS): GHS06,GHS08

Signal word: Danger

Hazard statements: H301+H311-H330-H372

Precautionary statements: P280-P301+P310+P330-P302+P352+P312-P304+P340+P310-P314

RIDADR: UN1170 - class 3 - PG 2 - Ethanol, solution

HS Code: 2936299055

Hazardous Substances Data: 131918-61-1(Hazardous Substances Data)

Use

Paricalcitol was launched as Zemplar in the US for the prevention and treatment of secondary hyperthyroidism associated with chronic renal failure. Paricalcitol is a synthetic vitamin D2, namely a novel 1-alpha-hydroxy-19-noranalogue in which the ring A exocyclic methylene group, typical of all vitamin D systems, has been replaced by two hydrogen atoms. Paricalcitol is the first vitamin D analogue marketed for this indication. In patients with chronic renal failure, Paricalcitol appreciably reduced levels of parathyroid hormone (PTH) without a significant difference in the incidence rate for hypercalcemia or hyperphosphatemia when compared with placebo.

You can find Paricalcitol suppliers, manufacturers, and distributors from countries such as China, United States and the India here. Browse to the tetrahydrofuran product information displayed by the supplier, as well as the supplier's contact and capability information.